| |
| |
|
| Insider
Information: |
Shandell Jason B. |
| Relationship: |
President and General ... |
| City: |
Rancho Cucamonga |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
179,276 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,171,040 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
179,276 |
|
|
| Total
Value |
$7,171,040 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amphastar Pharmaceuticals, Inc. |
AMPH |
President and General ... |
2020-03-17 |
179,276 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
85 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2016-11-28 |
4 |
OE |
$10.93 |
$265,512 |
D/D |
24,292 |
227,253 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2016-11-28 |
4 |
AS |
$20.47 |
$497,201 |
D/D |
(24,292) |
202,961 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2017-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
63,670 |
266,871 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2017-03-17 |
4 |
D |
$13.75 |
$96,924 |
D/D |
(7,049) |
259,822 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2017-03-26 |
4 |
D |
$13.76 |
$64,865 |
D/D |
(4,714) |
255,108 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2017-03-27 |
4 |
D |
$14.27 |
$84,735 |
D/D |
(5,938) |
249,170 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
– • – |
2017-05-30 |
4 |
S |
$16.76 |
$131,230 |
D/D |
(7,828) |
241,342 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
– • – |
2017-05-31 |
4 |
S |
$17.26 |
$63,070 |
D/D |
(3,654) |
237,688 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2017-07-05 |
4 |
D |
$17.95 |
$60,922 |
D/D |
(3,394) |
235,493 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2018-01-25 |
4 |
AS |
$19.26 |
$166,822 |
D/D |
(8,661) |
226,914 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2018-01-26 |
4 |
AS |
$19.56 |
$194,925 |
D/D |
(9,966) |
216,948 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2018-03-13 |
4 |
OE |
$11.79 |
$3,537 |
D/D |
300 |
217,248 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2018-03-13 |
4 |
AS |
$20.45 |
$6,135 |
D/D |
(300) |
216,948 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2018-03-14 |
4 |
OE |
$11.79 |
$4,716 |
D/D |
400 |
217,348 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2018-03-14 |
4 |
AS |
$20.45 |
$8,180 |
D/D |
(400) |
216,948 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2018-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
39,919 |
256,867 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2018-03-16 |
4 |
D |
$19.91 |
$109,405 |
D/D |
(5,495) |
251,372 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2018-03-17 |
4 |
D |
$19.91 |
$129,136 |
D/D |
(6,486) |
244,886 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2018-03-19 |
4 |
AS |
$19.37 |
$226,767 |
D/D |
(11,707) |
233,179 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2018-03-20 |
4 |
AS |
$19.52 |
$161,871 |
D/D |
(8,293) |
224,886 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2018-03-26 |
4 |
D |
$18.61 |
$83,596 |
D/D |
(4,492) |
220,394 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2018-03-27 |
4 |
D |
$18.47 |
$144,676 |
D/D |
(7,833) |
212,561 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2018-07-11 |
4 |
AS |
$16.77 |
$241,422 |
D/D |
(14,399) |
199,505 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2018-11-08 |
4 |
AS |
$20.68 |
$748,586 |
D/D |
(36,201) |
199,505 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
President and General Counsel |
• • – |
2018-11-08 |
4 |
OE |
$10.46 |
$385,711 |
D/D |
36,201 |
235,706 |
0 |
- |
|
85 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
